252
Views
10
CrossRef citations to date
0
Altmetric
TRANSLATIONAL RESEARCHDIFFERENTIAL GENE EXPRESSION IN HUMAN FIBROBLASTS FOLLOWING EXPOSURE TO DIFFERENT RADIATION QUALITIES

Differential gene expression in human fibroblasts after alpha-particle emitter 211At compared with 60Co irradiation

, , , , , , , & show all
Pages 250-258 | Received 08 May 2012, Accepted 21 Oct 2012, Published online: 14 Dec 2012
 

Abstract

Purpose: The aim of this study was to identify gene expression profiles distinguishing alpha-particle 211At and 60Co irradiation.

Materials and methods: Gene expression microarray profiling was performed using total RNA from confluent human fibroblasts 5 hours after exposure to 211At labeled trastuzumab monoclonal antibody (0.25, 0.5, and 1 Gy) and 60Co (1, 2, and 3 Gy).

Results: We report gene expression profiles that distinguish the effect different radiation qualities and absorbed doses have on cellular functions in human fibroblasts. In addition, we identified commonly expressed transcripts between 211At and 60Co irradiation. A greater number of transcripts were modulated by 211At than 60Co irradiation. In addition, down-regulation was more prevalent than up-regulation following 211At irradiation. Several biological processes were enriched for both irradiation qualities such as transcription, cell cycle regulation, and cell cycle arrest, whereas mitosis, spindle assembly checkpoint, and apoptotic chromosome condensation were uniquely enriched for alpha particle irradiation.

Conclusions: LET-dependent transcriptional modulations were observed in human fibroblasts 5 hours after irradiation exposure. These findings suggest that in comparison with 60Co, 211At has the clearest influence on both tumor protein p53-activated and repressed genes, which impose a greater overall burden to the cell following alpha particle irradiation.

Acknowledgements

The authors thank Sture Lindegren for distillation and labeling of 211At and Ulla Delle for flow cytometric analysis.

Declaration of interest The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

This work was supported by the King Gustav V Jubilee Clinic Cancer Research Foundation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.